Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 3Phase 1 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Lymphoma 22Breast Neoplasms 16Leukemia 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Hodgkin Disease 11Neuroblastoma 10Lymphoma, Follicular 10Burkitt Lymphoma 10Leukemia, Myeloid, Acute 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neutropenia 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Neoplasms, Plasma Cell 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Malignant mesenchymal tumor 5Congenital Abnormalities 5Rhabdomyosarcoma 4Leukemia, Myeloid, Chronic-Phase 4Kidney Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Endometrial Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4

Interventions

Gemcitabine 28Cisplatin 26Mitomycin 18BCG Vaccine 12pembrolizumab 9Paclitaxel 8Doxorubicin 7Docetaxel 75-aminolevulinic acid hexyl ester 7apaziquone 6Carboplatin 6vinflunine 5enfortumab vedotin 5atezolizumab 5Vinblastine 5Radiotherapy 5Methotrexate 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cystectomy 5durvalumab 4Surgical Procedures, Operative 4Nivolumab 4Transurethral Resection of Bladder 3Specimen Handling 3Selenium 3Radiation 3Filgrastim 3Cystoscopy 3BCG Connaught 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Urinary Bladder Neoplasms × Filgrastim × Clear all
NCT00028756 2016-08-02

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
285 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00014534 2016-07-14

Combination Chemotherapy in Treating Patients With Bladder Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
42 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00237575 2012-05-23

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

University of Kentucky

Phase 3 Terminated
100 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡